RxDoctor Payments DataLook up a doctor →

Jeffry Strohmyer, MD

Family Medicine · Papillion, NENPI 1275565939

Payments from drug & device makers

$9,267in general payments, 2019–2025

Across 573 payments — averaging $16.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • AbbVie$909
  • Novo Nordisk$863
  • Lilly USA, LLC$571
  • GSK$565
  • Bayer$358
  • plus $5K from 48 others

General payments by program year

19
20
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca47$1,055
AbbVie(2 entities)66$909
Novo Nordisk63$863
Lilly USA, LLC45$571
GSK15$565
Bayer25$358
Takeda Pharmaceuticals U.S.A., Inc.23$330
Johnson & Johnson20$317
Pfizer21$315
Kowa Pharmaceuticals America, Inc.23$311
Novartis22$310
Amgen16$271
Merck24$256
Amarin Pharma, Inc.15$237
Otsuka America Pharmaceutical, Inc.13$220
Supernus Pharmaceuticals, Inc.5$180
Biohaven Pharmaceutical Holding Company Ltd.12$168
Astellas Pharma US Inc9$152
Grifols USA, LLC7$128
Boehringer Ingelheim7$109
Ironwood Pharmaceuticals, Inc7$108
Genentech USA, Inc.6$104
Bausch Health US, LLC5$99
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC7$96
Avanir Pharmaceuticals, Inc.7$92
Actelion Pharmaceuticals US, Inc.2$81
Bristol Myers Squibb5$69
Nestle Healthcare Nutrition Inc.4$67
Sunovion Pharmaceuticals Inc.6$65
Medicure Pharma Inc.1$60
Nevro Corp.3$59
Itamar Medical Inc1$55
Arbor Pharmaceuticals, Inc.3$52
Esperion Therapeutics, Inc.3$51
Jazz Pharmaceuticals Inc.3$48
Biohaven Pharmaceuticals, Inc.2$46
Eisai Inc.3$44
Axsome Therapeutics, Inc.2$42
E.r. Squibb & Sons, L.L.C.3$41
Antares Pharma, Inc.2$39
Sumitomo Pharma America, Inc.3$38
Sanofi-aventis U.S. LLC2$35
Abbott2$33
Neos Therapeutics, LP2$28
Averitas Pharma Inc.1$26
Promius Pharma LLC2$26
Philips North America LLC1$23
Adlon Therapeutics L.p.1$19
Upsher-smith Laboratories LLC1$18
Ultragenyx Pharmaceutical Inc.1$17
Boston Scientific1$17
Forte Bio-pharma LLC1$17
Paratek Pharmaceuticals, Inc.1$14
Teva Pharmaceuticals USA, Inc.1$12

How this compares

$9,267 in reported general payments places this provider in the 90th percentile of 981 family medicine providers in Nebraska.

See all family medicine providers in Nebraska →

Medicare billing

Part B allowed, 2024
$115,770
Medicare patients
468
Services billed
2,856

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Papillion

See the full list for Nebraska →

Where these figures come from

Is this you, or does something look wrong? →